Discovery of a potent and selective PARP1 degrader promoting cell cycle arrest via intercepting CDC25C-CDK1 axis for treating triple-negative breast cancer.
Wu Y, Wu M, Zheng X, Yu H, Mao X, Jin Y, Wang Y, Pang A, Zhang J, Zeng S, Xu T, Chen Y, Zhang B, Lin N, Dai H, Wang Y, Yao X, Dong X, Huang W, Che J.
Wu Y, et al. Among authors: chen y.
Bioorg Chem. 2024 Jan;142:106952. doi: 10.1016/j.bioorg.2023.106952. Epub 2023 Nov 8.
Bioorg Chem. 2024.
PMID: 37952486